ESOT 2013 Report – Pushing the limit in clinical science
by Peter Friend, Oxford, UK – The 16th ESOT Congress in Vienna 2013 was one of ESOT’s most comprehensive arrangements to date, with more than 3,500 attendees and… read more.
by Peter Friend, Oxford, UK – The 16th ESOT Congress in Vienna 2013 was one of ESOT’s most comprehensive arrangements to date, with more than 3,500 attendees and… read more.
Randall Morris, San Francisco, USA – Failure to make therapeutic progress is a real challenge in the transplantation field. On the face of it, the goals set up… read more.
Richard Trompeter, London, UK; Jo Wray, London, UK; Lorraine Bell, Montreal, Canada – The transition from paediatric to adult transplantation services is a major challenge for adolescent transplant… read more.
Richard Trompeter, London, UK; Jo Wray, London, UK; Lorraine Bell, Montreal, Canada – The transition from paediatric to adult transplantation services is a major challenge for adolescent transplant… read more.
Andreas Tzakis , Weston, USA – Advances in vascular reconstruction techniques in recent years has transformed the concept of multi-visceral or cluster transplantations from the very forefront of… read more.
Reducing or eliminating the need for chronic immunosuppressive therapy by inducing tolerance in the recipient immune system would have an astounding impact on clinical practice and scientists all… read more.
by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.
by Maria Dalby – Donor-specific anti-human leukocyte antigen (HLA) antibodies, or DSAs, have emerged in recent years as one of the most important factors for predicting the outcome… read more.
Johns Hopkins researchers see 21-fold increase in a single day. A social media push boosted the number of people who registered themselves as organ donors 21-fold in a… read more.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.